DR REDDYS LABORATORIES allotted 375 fully paid Equity shares on September 10, 2026, after eligible employees exercised Options under its 2007 ADR stock option scheme. The shares carry Re.1 par value, were issued at Re.1 per share with nil premium, and rank equally with existing equity.

Key Highlights

  • Employees exercised options at Re.1 per share, with nil premium.
  • The new equity ranks pari passu with existing shares and carries no lock-in.
  • Dr. Reddy’s Laboratories allotted the 375 fully paid equity shares on September 10, 2026.

DR REDDYS LABORATORIES LTD (NYSE: RDY) allotted 375 fully paid equity shares on September 10, 2026, following eligible employee exercises under its stock option programme. The shares rank equally with existing equity.

Employee Options Exercised at Re.1

The securities are equity shares with a Par Value of Re.1 each. Their distinctive numbers run from 834,679,911 to 834,680,285, and their ISIN is INE089A01031. No share certificate number applies, and the allotment carries no lock-in or lock-in expiry date. The allotment followed the company’s ADR stock option scheme, which was established under earlier employee-option rules and complies with the 2021 share-based employee benefit regulations.

Issued Shares and Paid-Up Capital

The filing notes a difference of 1,000 between total Issued Shares and total paid-up shares. Dr. Reddy’s Laboratories attributes that difference to shares forfeited in September 1988 because allotment money was not paid. The newly allotted shares are identical in all respects to existing shares and rank pari passu with them.